08:55 AM EDT, 08/25/2025 (MT Newswires) -- Health care stocks were steady pre-bell Monday, with The Health Care Select Sector SPDR Fund (XLV) declining marginally and the iShares Biotechnology ETF (IBB) inactive.

Argenx (ARGX) stock was more than 3% higher after the company said a phase 3 study of its drug Vyvgart met its primary endpoint in treating patients with AChR-Ab seronegative generalized myasthenia gravis, an autoimmune disease.